Kornitzer Capital Management Inc. KS cut its position in shares of Clorox Co. (NYSE:CLX) by 27.0% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 320,198 shares of the company’s stock after selling 118,185 shares during the period. Clorox accounts for approximately 0.8% of Kornitzer Capital Management Inc. KS’s portfolio, making the stock its 22nd largest position. Kornitzer Capital Management Inc. KS owned 0.25% of Clorox worth $44,312,000 as of its most recent filing with the SEC.

Several other institutional investors also recently made changes to their positions in CLX. Legal & General Group Plc increased its position in shares of Clorox by 1.7% in the first quarter. Legal & General Group Plc now owns 682,421 shares of the company’s stock worth $86,041,000 after buying an additional 11,428 shares in the last quarter. First Republic Investment Management Inc. increased its position in shares of Clorox by 5.7% in the first quarter. First Republic Investment Management Inc. now owns 200,233 shares of the company’s stock worth $25,242,000 after buying an additional 10,868 shares in the last quarter. Boston Advisors LLC increased its position in shares of Clorox by 14.3% in the second quarter. Boston Advisors LLC now owns 196,360 shares of the company’s stock worth $27,174,000 after buying an additional 24,501 shares in the last quarter. Sabal Trust CO increased its position in shares of Clorox by 2.9% in the second quarter. Sabal Trust CO now owns 163,636 shares of the company’s stock worth $22,645,000 after buying an additional 4,571 shares in the last quarter. Finally, Shell Asset Management Co. increased its position in shares of Clorox by 9.6% in the second quarter. Shell Asset Management Co. now owns 103,486 shares of the company’s stock worth $14,321,000 after buying an additional 9,034 shares in the last quarter. Institutional investors and hedge funds own 70.21% of the company’s stock.

Institutional Ownership by Quarter for Clorox (NYSE:CLX)

Clorox Co. (NYSE:CLX) traded down 0.61% during midday trading on Friday, hitting $121.77. 541,431 shares of the company traded hands. Clorox Co. has a 12-month low of $119.23 and a 12-month high of $140.47. The company has a market cap of $15.77 billion, a PE ratio of 24.75 and a beta of 0.29. The stock has a 50 day moving average price of $125.59 and a 200-day moving average price of $129.72.

Clorox (NYSE:CLX) last posted its quarterly earnings data on Wednesday, August 3rd. The company reported $1.26 earnings per share for the quarter, missing the consensus estimate of $1.28 by $0.02. The company earned $1.60 billion during the quarter, compared to analyst estimates of $1.58 billion. Clorox had a return on equity of 296.91% and a net margin of 11.25%. The business’s revenue for the quarter was up 2.8% compared to the same quarter last year. During the same period in the previous year, the company earned $1.44 EPS. Analysts expect that Clorox Co. will post $5.49 EPS for the current year.

The firm also recently declared a quarterly dividend, which will be paid on Monday, November 14th. Shareholders of record on Wednesday, October 26th will be given a $0.80 dividend. This represents a $3.20 annualized dividend and a yield of 2.61%. The ex-dividend date of this dividend is Monday, October 24th. Clorox’s dividend payout ratio (DPR) is presently 64.91%.

CLX has been the subject of several recent research reports. Zacks Investment Research downgraded shares of Clorox from a “buy” rating to a “hold” rating in a report on Tuesday, October 4th. Atlantic Securities upgraded shares of Clorox from a “hold” rating to a “buy” rating and set a $144.00 target price for the company in a report on Friday, September 16th. Deutsche Bank AG restated a “hold” rating and set a $134.00 target price (up from $130.00) on shares of Clorox in a report on Sunday, July 24th. Jefferies Group restated a “hold” rating on shares of Clorox in a report on Wednesday, August 3rd. Finally, Goldman Sachs Group Inc. restated a “neutral” rating and set a $131.00 target price (up from $125.00) on shares of Clorox in a report on Friday, July 15th. Two analysts have rated the stock with a sell rating, seven have given a hold rating and two have assigned a buy rating to the stock. The company currently has a consensus rating of “Hold” and an average target price of $127.80.

In other Clorox news, SVP Jon M. Balousek sold 5,136 shares of the business’s stock in a transaction dated Monday, August 29th. The shares were sold at an average price of $131.14, for a total value of $673,535.04. Following the sale, the senior vice president now directly owns 15,384 shares in the company, valued at $2,017,457.76. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, COO Dawn C. Willoughby sold 10,617 shares of the business’s stock in a transaction dated Wednesday, August 17th. The stock was sold at an average price of $131.01, for a total transaction of $1,390,933.17. Following the completion of the sale, the chief operating officer now owns 20,353 shares in the company, valued at $2,666,446.53. The disclosure for this sale can be found here. 0.74% of the stock is currently owned by company insiders.

Clorox Company Profile

The Clorox Company is a manufacturer and marketer of consumer and professional products. The Company sells its products primarily through mass retail outlets, e-commerce channels, wholesale distributors and medical supply distributors. The Company operates through four segments: Cleaning, Household, Lifestyle and International.

5 Day Chart for NYSE:CLX

Receive News & Stock Ratings for Clorox Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox Co. and related stocks with our FREE daily email newsletter.